Regulatory protein:
CD38	S214-p
FGFR1	Y134-p

Treatment:
angiotensin-(1-7)	S214-p
angiotensin_2	S107-p , S113-p
AZD1152	S214-p
BI2536	S9-p , S222-p
BI_4834	S164-p , T301-p
dasatinib	S182-p , S183-p , S186-p , S190-p
EGF	S182-p , S183-p , S186-p , S190-p
FGF2	Y134-p
ischemia	S107-p
metastatic potential	S135-p , S137-p , S214-p
metformin	S113-p , S190-p , S214-p
nocodazole	S66-p , T78-p , S107-p , S113-p , S182-p , S190-p , T301-p , S1168-p
selumetinib	S182-p , S186-p , S190-p , T301-p
SII_angiotensin_2	S107-p , S113-p , S182-p , S183-p , S190-p
U0126	S183-p , S190-p , S214-p
vemurafenib	S182-p , S186-p , S190-p
ZM447439	S214-p